10x Genomics Blog May 21, 2026 Is It Time To Reassess 10x Genomics (TXG) After Its 188% One Year Share Price Surge - simplywall.st
10x Genomics Blog May 19, 2026 10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
10x Genomics Blog May 19, 2026 10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
10x Genomics Blog May 18, 2026 The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo! Finance Canada
10x Genomics Blog May 17, 2026 The Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance - Sahm
10x Genomics Blog May 13, 2026 Analysts Are Updating Their 10x Genomics, Inc. (NASDAQ:TXG) Estimates After Its First-Quarter Results - simplywall.st
10x Genomics Blog May 13, 2026 Is It Time To Reassess 10x Genomics (TXG) After Its Recent Share Price Surge? - Yahoo Finance
10x Genomics Blog May 13, 2026 10x Genomics, Harvard Target Element’s Multiomics Platform in Patent Lawsuit - Genetic Engineering and Biotechnology News
10x Genomics Blog May 12, 2026 Morgan Stanley Lifts Price Target on 10x Genomics to $22 From $20, Keeps Equalweight Rating - Moomoo
10x Genomics Blog May 8, 2026 10x Genomics (TXG) Loss Reduction To US$0.35 TTM EPS Challenges Bearish Profitability Narrative - simplywall.st
10x Genomics Blog May 8, 2026 Harvard, 10x Patent Suit Targets Newer Cell-Mapping Platform - Bloomberg Law News